Tango Therapeutics, Inc.TNGXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing targeted therapies and novel immunotherapies for patients with hard-to-treat cancers. Its core pipeline targets genetic vulnerabilities in tumor cells, with key programs targeting mutations common across multiple solid tumor types, serving global oncology populations via in-house R&D and industry partnerships.